NBY - NovaBay Pharmaceuticals, Inc.

1.48
0.050   3.378%

Share volume: 261,107
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.15%

PREVIOUS CLOSE
CHG
CHG%
$1.43
0.05
0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
25%
Profitability 25%
Dept financing 20%
Liquidity 73%
Performance 15%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
2.78%
1 Month
55.79%
3 Months
35.78%
6 Months
-64.93%
1 Year
135.89%
2 Year
-71.81%
Key data
Stock price
$1.48
P/E Ratio 
2.30
DAY RANGE
$1.36 - $1.58
EPS 
$0.74
52 WEEK RANGE
$0.43 - $19.95
52 WEEK CHANGE
$154.95
MARKET CAP 
7.454 M
YIELD 
62.50%
SHARES OUTSTANDING 
126.011 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-08-2025
BETA 
2.69
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$544,894
AVERAGE 30 VOLUME 
$1,654,413
Company detail
CEO: Justin M. Hall
Region: US
Website: novabay.com
Employees: 30
IPO year: 2007
Issue type: Common Stock
Market: NYSE American
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

NovaBay Pharmaceuticals, Inc. develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials from skin around the eye, such as the eyelid. The company also provides dermatological solutions for acne, skin care, and skin care products under the DERMAdoctor brand.

Recent news